PIA
FBIO icon

Piedmont Investment Advisors’s Fortress Biotech FBIO Stock Holding History

Piedmont Investment Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39
Closed -$2K – 1444
2018
Q2 		$2K Buy
+39
New +$2.2K ﹤0.01% 2568

Other funds holding FBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Piedmont Investment Advisors's FBIO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Fortress Biotech (FBIO) in Q3 2018, closing a stake of 39 shares — an estimated $2K sold.

Piedmont Investment Advisors first reported a position in FBIO in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 65 funds tracked by Wall St. Rank hold FBIO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Fortress Biotech position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 39 Fortress Biotech shares in Q3 2018, an estimated $2K.
  • Piedmont Investment Advisors first reported a position in Fortress Biotech in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Fortress Biotech position peaked at $2K in Q2 2018.
  • 65 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.